Aclasta (Zolendrate Acid) is a new and innovative, once every 18 month, osteoporosis treatment with the key to stronger bones. It has been trialled through the public system and now is available to both public and private patients who meet the criteria.
What is Osteoporosis?
Osteoporosis is one of the most common bone diseases affecting half (½) of women and one third (⅓) of men over the age of 60 years. It reduces bone quality and causes the bone to become brittle and break (Fracture).
What is the Aclasta Treatment?
Aclasta is a single intravenous IV infusion. It is an effective therapy to reduce bone fractures and is ideal for patients who are unable to tolerate oral bisphohates (Fosamax, Fosemoc plus and Edentates) or through lifestyle choice prefer to have an infusion every 18 months.
What are the side effects of the treatment?
The most common side effect is flu type symptoms which may last a few days with the help of paracetamol or ibuprofen (Nurofen). The IV medication is funded as long as you meet the required criteria.
Is there a charge for the treatment?
There is a charge for this procedure which covers pre-screening, a script and the procedure itself, which takes one hour.
When can I come to the clinic?
The Aclasta Clinic runs every Monday, 9 am- 12 pm.
Book Your Appointment
If you would like to take advantage of the Aclasta Clinic, please
make an appointment with your GP for a referral, or pick up a booklet
from our brochure racks.